2 terminated, 1 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Recurrent GBM: new trials by email Literature Review of Recurrent GBM trials Research Report on Recurrent GBM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Recurrent GBM | Phase 1 / Phase 2 | Terminated | SonALAsense, Inc. | 8 | 2023-02-06 | 2024-07-26 |
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab Radiation: Intra-operative Radiation Therapy - IORT, Bevacizumab - Glioblastoma, Recurrent Glioblastoma | Phase 2 | Terminated | Xoft, Inc. | 12 | 2021-11-02 | 2024-04-26 |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma Cerebraca wafer - Recurrent GBM | Phase 1 / Phase 2 | Completed | Everfront Biotech Co., Ltd. | 22 | 2017-11-01 | 2024-09-19 |
Glioblastoma (3) · Astrocytoma (1) · Glioma (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Astrocytoma (2) · Glioma (2)
Bevacizumab (1)
Everfront Biotech Co., Ltd. (1) · SonALAsense, Inc. (1) · Xoft, Inc. (1)
United States (2) · Taiwan (1)
Corina Andresen, MD (1) · Santosh Kesari, MD (1)
R44CA275508 (1)